511 related articles for article (PubMed ID: 32192483)
1. The prognostic value of routine preoperative blood parameters in muscle-invasive bladder cancer.
Zhang J; Zhou X; Ding H; Wang L; Liu S; Liu Y; Chen Z
BMC Urol; 2020 Mar; 20(1):31. PubMed ID: 32192483
[TBL] [Abstract][Full Text] [Related]
2. Preoperative neutrophil-lymphocyte ratio can significantly predict mortality outcomes in patients with non-muscle invasive bladder cancer undergoing transurethral resection of bladder tumor.
Kang M; Jeong CW; Kwak C; Kim HH; Ku JH
Oncotarget; 2017 Feb; 8(8):12891-12901. PubMed ID: 28039452
[TBL] [Abstract][Full Text] [Related]
3. Comparison of Preoperative Neutrophil-Lymphocyte and Platelet-Lymphocyte Ratios in Bladder Cancer Patients Undergoing Radical Cystectomy.
Wang R; Yan Y; Liu S; Yao X
Biomed Res Int; 2019; 2019():3628384. PubMed ID: 31662975
[TBL] [Abstract][Full Text] [Related]
4. Prognostic Value of the Preoperative Platelet-to-leukocyte Ratio for Oncologic Outcomes in Patients Undergoing Radical Cystectomy for Bladder Cancer.
Schulz GB; Grimm T; Buchner A; Jokisch F; Grabbert M; Schneevoigt BS; Kretschmer A; Stief CG; Karl A
Clin Genitourin Cancer; 2017 Dec; 15(6):e915-e921. PubMed ID: 28587816
[TBL] [Abstract][Full Text] [Related]
5. Prognostic impact of perioperative lymphocyte-monocyte ratio in patients with bladder cancer undergoing radical cystectomy.
Yoshida T; Kinoshita H; Yoshida K; Mishima T; Yanishi M; Inui H; Komai Y; Sugi M; Inoue T; Murota T; Fukui K; Harada J; Kawa G; Matsuda T
Tumour Biol; 2016 Aug; 37(8):10067-74. PubMed ID: 26819209
[TBL] [Abstract][Full Text] [Related]
6. Pretreatment neutrophil-to-lymphocyte ratio is associated with advanced pathologic tumor stage and increased cancer-specific mortality among patients with urothelial carcinoma of the bladder undergoing radical cystectomy.
Viers BR; Boorjian SA; Frank I; Tarrell RF; Thapa P; Karnes RJ; Thompson RH; Tollefson MK
Eur Urol; 2014 Dec; 66(6):1157-64. PubMed ID: 24630414
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of neutrophil-to-lymphocyte ratio and establishment of novel preoperative risk stratification model in bladder cancer patients treated with radical cystectomy.
Gondo T; Nakashima J; Ohno Y; Choichiro O; Horiguchi Y; Namiki K; Yoshioka K; Ohori M; Hatano T; Tachibana M
Urology; 2012 May; 79(5):1085-91. PubMed ID: 22446338
[TBL] [Abstract][Full Text] [Related]
8. Impact of preoperative hemoglobin and CRP levels on cancer-specific survival in patients undergoing radical cystectomy for transitional cell carcinoma of the bladder: results of a single-center study.
Grimm T; Buchner A; Schneevoigt B; Kretschmer A; Apfelbeck M; Grabbert M; Jokisch JF; Stief CG; Karl A
World J Urol; 2016 May; 34(5):703-8. PubMed ID: 26376992
[TBL] [Abstract][Full Text] [Related]
9. Sarcopenia as a Novel Preoperative Prognostic Predictor for Survival in Patients with Bladder Cancer Undergoing Radical Cystectomy.
Hirasawa Y; Nakashima J; Yunaiyama D; Sugihara T; Gondo T; Nakagami Y; Horiguchi Y; Ohno Y; Namiki K; Ohori M; Tokuuye K; Tachibana M
Ann Surg Oncol; 2016 Dec; 23(Suppl 5):1048-1054. PubMed ID: 27699608
[TBL] [Abstract][Full Text] [Related]
10. Preoperative chronic kidney disease is predictive of oncological outcome of radical cystectomy for bladder cancer.
Matsumoto A; Nakagawa T; Kanatani A; Ikeda M; Kawai T; Miyakawa J; Taguchi S; Naito A; Otsuka M; Nakanishi Y; Suzuki M; Koga F; Nagase Y; Kondo Y; Okaneya T; Tanaka Y; Miyazaki H; Fujimura T; Fukuhara H; Kume H; Igawa Y; Homma Y
World J Urol; 2018 Feb; 36(2):249-256. PubMed ID: 29185045
[TBL] [Abstract][Full Text] [Related]
11. Can the Preoperative Neutrophil-to-Lymphocyte Ratio Significantly Predict the Conditional Survival Probability in Muscle-invasive Bladder Cancer Patients Undergoing Radical Cystectomy?
Kang M; Balpukov UJ; Jeong CW; Kwak C; Kim HH; Ku JH
Clin Genitourin Cancer; 2017 Jun; 15(3):e411-e420. PubMed ID: 28162942
[TBL] [Abstract][Full Text] [Related]
12. Predictive value of pretreatment inflammation-based prognostic scores (neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and lymphocyte-to-monocyte ratio) for invasive bladder carcinoma.
Lee SM; Russell A; Hellawell G
Korean J Urol; 2015 Nov; 56(11):749-55. PubMed ID: 26568792
[TBL] [Abstract][Full Text] [Related]
13. Preoperative lymphocyte-monocyte and platelet-lymphocyte ratios as predictors of overall survival in patients with bladder cancer undergoing radical cystectomy.
Zhang GM; Zhu Y; Luo L; Wan FN; Zhu YP; Sun LJ; Ye DW
Tumour Biol; 2015 Nov; 36(11):8537-43. PubMed ID: 26032095
[TBL] [Abstract][Full Text] [Related]
14. Identification of the best complete blood count-based predictors for bladder cancer outcomes in patients undergoing radical cystectomy.
Bhindi B; Hermanns T; Wei Y; Yu J; Richard PO; Wettstein MS; Templeton A; Li K; Sridhar SS; Jewett MA; Fleshner NE; Zlotta AR; Kulkarni GS
Br J Cancer; 2016 Jan; 114(2):207-12. PubMed ID: 26657651
[TBL] [Abstract][Full Text] [Related]
15. Pre-treatment neutrophil-to-lymphocyte ratio as predictor of adverse outcomes in patients undergoing radical cystectomy for urothelial carcinoma of the bladder.
Hermanns T; Bhindi B; Wei Y; Yu J; Noon AP; Richard PO; Bhatt JR; Almatar A; Jewett MA; Fleshner NE; Zlotta AR; Templeton AJ; Kulkarni GS
Br J Cancer; 2014 Jul; 111(3):444-51. PubMed ID: 24918819
[TBL] [Abstract][Full Text] [Related]
16. Promising role of preoperative neutrophil-to-lymphocyte ratio in patients treated with radical nephroureterectomy.
Vartolomei MD; Mathieu R; Margulis V; Karam JA; Rouprêt M; Lucca I; Mbeutcha A; Seitz C; Karakiewicz PI; Fajkovic H; Wood CG; Weizer AZ; Raman JD; Rioux-Leclercq N; Haitel A; Bensalah K; Rink M; Briganti A; Xylinas E; Shariat SF
World J Urol; 2017 Jan; 35(1):121-130. PubMed ID: 27209168
[TBL] [Abstract][Full Text] [Related]
17. Karnofsky performance status predicts overall survival, cancer-specific survival, and progression-free survival following radical cystectomy for urothelial carcinoma.
Evers PD; Logan JE; Sills V; Chin AI
World J Urol; 2014 Apr; 32(2):385-91. PubMed ID: 23756991
[TBL] [Abstract][Full Text] [Related]
18. Gemcitabine based trimodality treatment in patients with muscle invasive bladder cancer: May neutrophil lymphocyte and platelet lymphocyte ratios predict outcomes?
Hurmuz P; Ozyigit G; Kilickap S; Esen CSB; Akdogan B; Ozen H; Akyol F
Urol Oncol; 2021 Jun; 39(6):368.e19-368.e29. PubMed ID: 33189528
[TBL] [Abstract][Full Text] [Related]
19. Low Pretreatment Neutrophil-to-Lymphocyte Ratio Predicts for Good Outcomes in Patients Receiving Neoadjuvant Chemotherapy Before Radical Cystectomy for Muscle Invasive Bladder Cancer.
Buisan O; Orsola A; Areal J; Font A; Oliveira M; Martinez R; Ibarz L
Clin Genitourin Cancer; 2017 Feb; 15(1):145-151.e2. PubMed ID: 27364982
[TBL] [Abstract][Full Text] [Related]
20. Impact of Routine Laboratory Parameters in Patients Undergoing Radical Cystectomy for Urothelial Carcinoma of the Bladder: A Long-Term Follow-Up.
Tamalunas A; Buchner A; Kretschmer A; Jokisch F; Schulz G; Eismann L; Stief CG; Grimm T
Urol Int; 2020; 104(7-8):551-558. PubMed ID: 32114587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
